ELSO - Extracorporeal Life Support Organization

Home
United States
Ann Arbor, MI
ELSO - Extracorporeal Life Support Organization

ELSO Membership
ECMO clinicians, research scientists, and members of regulatory and public health institutions are now eligible for membership in ELSO.
(1)

Vision Statement

ELSO will be the premier organization providing education, training, research, and data management for the advancement of extracorporeal life support throughout the world. Mission statement

To provide support to institutions delivering extracorporeal life support through continuing education, guidelines development, original research, publications and maintenance of a comprehens

ive registry of patient data. The guiding principles of ELSO are:

Innovation: Seeking to identify and promote advances for the application of extracorporeal therapies

Expertise: Bringing together world leaders in the care of critically ill patients for collaboration to advance quality of care through education and publication. Clinical support: Maintaining a comprehensive registry of data to assist in reducing morbidity and improving survival of patients requiring extracorporeal therapies. Community: Fostering communication and collaboration among professionals who apply advanced technologies in the treatment of refractory organ failure.

09/03/2026

📱 Did you download the ELSO's Bedside Guide ⁉️ Your essential, free guide for managing patients receiving extracorporeal membrane oxygenation:
⚖️ assess candidacy
📦 equipment
📋 checklists
🧮 calculators
💉 medications in
📚 resources
and the amazing
⚠️ Panic button for troubleshooting emergencies

Download app for Apple at:
📱 https://bit.ly/ELSOBedsideGuideA
Download app for Android at:
📱 https://bit.ly/ELSOBedsideGuideG

09/02/2026

Long-term mortality & functional outcomes among adults treated with
🔍 systematic review/meta-analysis including 163 studies (RCTs + observational studies) and >78K patients
🪦 long-term mortality post remains high and continues to accrue over the long-term, with substantial variation by modality/clinical indication, ranging from 37.2% for VV to 74.4% for at 1 year, but heterogeneity between studies remains substantial
📚 functional outcomes (inconsistently) reported only in 23.3% of studies, including >7.8K survivors using CPC, WHODAS 2.0 or mRS, limiting the understanding of functional recovery among survivors
Standardized outcome reporting, and greater focus on survivorship and patient-centered outcomes in future research pivotal to better inform long-term prognosis/follow-up, patient selection, and factors that may improve functional recovery after support.
🖇️ https://bit.ly/3SDFuK3

09/01/2026

📢 The latest ELSO newsletter is out!
🖋️ Message from our President, Daniel Brodie
🛏 Circuit Chatter 8th Edition, submitted by Grace Van Leeuwen, Elisabetta Giacomini, Ibrahim Fawzy Hassan, Tayseer Mosleh from Sidra Medicine & Hamad Medical Corporation, discussing an interesting case of refractory hypoxemia on
📃 News from ELSO Committees opening with the ELSO Conference Committee: 📆 countdown for is ON: September 28- October 1, 2026 Nashville, Tennessee 🎶 🇺🇸!! Register at https://bit.ly/ELSO2026
❓ In this edition you can also take a look at the ELSO Registry Q&A Corner... Any question about definitions/data entry❓
🤝 Welcome to the new members of Board, Committees & Team, and congratulations to old members with new roles!
🎓 News form the Global Education Committee GEC
🌏 around the world, updates from ELSO Chapters including next annual meetings & conferences:
🇨🇷 : November 5-7 2026, San Jose - Costa Rica
🇸🇦 : January 28 - February 1, 2027, Najran, Saudi Arabia
🇦🇹 : April 28 - May 1 2027, Vienna - Austria
🇮🇩 : June 2027 Bali, Indonesia
🖋️ CEO Christine Stead remarks & more! Read all on ELSO website at
🔗 bit.ly/2IR8RCl
or check your e-mail if you are an ELSO member... otherwise consider joining!! See less

08/31/2026

🍂 Advance your expertise this fall at ELSO Headquarters in Ann Arbor, Michigan! Join us for our hands-on Cannulation and Simulation Courses, designed to build confidence, enhance clinical skills, and provide practical experience with expert-led instruction.

Adult course
📆 November 9-10, 2026 (🪑 few seats!!)
🚦 November 11-12, 2026 (fully booked - waitlist available)

Neo/Peds course
📆 October 13-14, 2026
PS next course anticipated Fall 2027...

Adult workshop
📆 October 11, 2026 (🪑 few seats!!)
📆 November 15, 2026 (🪑 few seats!!)
🚦 October 10, 2026 (fully booked - waitlist available)
🚦 November 13, 2026 (fully booked - waitlist available)
🚦 November 14, 2026 (fully booked - waitlist available)

📌 Location: ELSO - Extracorporeal Life Support Organization Headquarters, Ann Arbor MI

⏰ Courses are filling quickly. Reserve your spot today before registration closes!
🎓 bit.ly/ELSOAcademy
All info at 📬 [email protected]
Discounts may be available based on course, country of practice, role, health system agreement & more!

$Left ventricular unloading during VA in patients with refractory cardiogenic shock:🔍 target trial emulation analysis i...$

08/29/2026

Left ventricular unloading during VA in patients with refractory cardiogenic shock:
🔍 target trial emulation analysis including 264 patients on VA for ≥48h in 2 high-volume centers, 2019-2023
🫀 52.2% received VA-ECMO alone, 47.8% ECMO + LV unloading ( or microaxial flow pump within 24 h after ECMO initiation)
⚖️ early addition of LV unloading not associated with survival benefit at 60 day, nor with improved ECMO weaning rates, despite an increased incidence of device-related complications
Findings suggest that a non-selective approach to LV unloading may expose patients to unnecessary risks without improving outcomes; clinically meaningful benefits in carefully selected patient phenotypes cannot be excluded. Results of ongoing RCTs (UNLOAD-ECMO, EULODIA,EASE-ECMO, REMAP-ECMO) eagerly awaited to define optimal unloading strategies: indications, timing, modality.
Open access
🔓 https://rdcu.be/gXGJHYxag6Da

08/28/2026

📢 The 2025 Annual Report of the ELSO is now available on our website!! The Report reflects the continued growth of the organization, the science and practice of , and the growing bonds among our many chapters, clinicians and partners throughout the world. Unfortunately, it was also the year that we lost our founder, Dr. Robert H. Bartlett on October 20, 2025. This marks a new era, not just for ELSO, but for the entire field of extracorporeal life support. It is hard to overstate Dr. Bartlett's intluence. His impact spanned from scientific discovery to the mentorship of generations of students. Dr. Bartlett taught us all to be curious and humble, to pursue science in the interests of our patients. He was also a friend to so many of us throughout the world. While we celebrate ELSO's achievements of 2025, we look to honor Dr. Bartlett's legacy as we continue our work into the future by challenging ourselves to innovate, to inspire and to serve, as Dr. Bartlett always challenged us to do. Thank you for all you do every day.
📬 Letter from the Board
📃 Mission, vision, values
🏠 Patients & families
📜 Dr. Bartlett: early days at Michigan
🎤 ELSO's 36th annual conference
🏅 FELSO 2025 Cohort
🏅 Centers of Excellence
📆 Year in review
✈️ Chapter meetings
🗺️ Community & Collaboration
💵 Financial highlights
👑 ELSO Leadership
📬 CEO Comments
🕯️ In Memoriam - Robert H. Bartlett
Open access to read/download at
📖 https://bit.ly/4zKGUD7

08/27/2026

Challenging the (controversial) obesity paradox in VV
🔍 multicenter cohort study evaluating associations of BMI with mortality and ELSO-defined complications in adults in for severe
🔎 420 patients, 4️⃣ centers (2017-2025).
⚖️ median BMI 31kg/m2
🪦 in-hospital mortality 62%; each 1 kg/m2 increase in BMI independently associated with 6% higher odds of in-hospital mortality in non-COVID ARDS
⚖️ higher BMI associated with renal complications across ARDS etiologies
⚖️ higher BMI associated with infectious complications in non-COVID ARDS, with graded increases across WHO obesity classes
Findings challenge the obesity survival paradox in respiratory and support modeling BMI as a continuous risk factor for VV ECMO risk stratification, counseling, and complication mitigation. Absence of a futility threshold reinforces that BMI alone should not be considered absolute exclusion criterion for VV ECMO.
ASAIO Journal
🖇️ https://bit.ly/3UD4r8T

08/26/2026

The unknown "others" of neonatal respiratory
🔍 review of the ELSO Registry data on neonatal respiratory support aimed to reclassify "other and PPHN" patients into modern categories to improve understanding of indications & their diagnosis-specific outcomes
🫁 >3.2 K neonates included, Jan 2017 - Jul 2021, 41% = "other", 8% persistent pulmonary hypertension
🔎 survival was 74% for "other" group
🔎 following reclassification, survival ranged from 0% for alveolar capillary dysplasia to 92% for aspiration of non-meconium fluid.
As ECMO use continues to provide an important life-saving therapy for critically ill neonates with cardiopulmonary failure, more diagnosis-specific data needed to better understand outcomes. In April 2023, ELSO introduced a new workflow for entering the primary diagnosis for neonatal respiratory , with the goal of improving diagnostic accuracy and precision.
ASAIO Journal
🖇️ https://bit.ly/45Qeg5P

08/25/2026

🍼 Tiny Patients, Big Decisions: advances in neonatal ECMO
Explore the latest advances in neonatal ECMO and hear from experts tackling some of the most complex decisions in critical care during this session! Moderated by Denise Suttner, Robert DiGeronimo & Javier Kattan

🫘 Renal Anomalies on - Pavika Varma
🫁🫀 Oxygenation Index & VIS - Jonathan Lillie
🫀 PCRTO in neonatal ECMO - Giles Peek
🎤 Pumps and lungs: a panel discussion with Taylor Wild, Sarah Keene, Katie Klingen, Bradley Oelkers, Caroline Ozment, Desiree Bonadonna

Looking forward to welcoming you to our annual congress:
📌 Ga***rd Opryland Resort & Convention Center, Nashville, TN
📆 September 28, Pre-Conference
📆 September 29 - October 1, Main Conference
Registrations are open:
🖇️ https://bit.ly/ELSO2026
🏨 PS Be sure to book your hotel through the conference website soon! Room block ends in 2 days, on August 27, 2026 ⏰ (First-come, first-serve)

08/24/2026

Preoperative stabilization before surgery in patients with cardiogenic shock secondary to valvular dysfunction: moving from traditional VA to LAVA
🌋 case series including 4 high-risk patients with acute severe mitral regurgitation or obstructive aortic stenosis
🔍 all patients survived to hospital discharge, despite an extreme predicted operative risk according to STS-PROM scores.
In carefully selected patients with in acute valvular failure, LAVA-ECMO may be an effective rescue strategy, combined with a multidisciplinary heart team approach. Principal advantage of left atrial venoarterial ECMO may extend beyond circulatory support to include effective left-sided decompression, particularly when rapid stabilization is required as a bridge to definitive surgical valve replacement.
ASAIO Journal
🖇️ https://bit.ly/4wIaI0j

Address

3001 Miller Road
Ann Arbor, MI
48103

Website

http://www.elso.org/

Alerts

Be the first to know and let us send you an email when ELSO - Extracorporeal Life Support Organization posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ELSO - Extracorporeal Life Support Organization:

Want your business to be the top-listed Health & Beauty Business in Ann Arbor?